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Background Troponin is a crucial biomarker for the diagnosis of an acute coronary syndrome (ACS). It rises in response
to myocardial injury from significant acute myocardial ischaemia caused by obstructive coronary artery disease
[‘classical’ myocardial infarction (MI)]. However, raised levels have also been noted in conditions not recognized as
classical ACS. This may include MI with non-obstructed coronary arteries such as takotsubo cardiomyopathy and
other acute or chronic conditions such as pulmonary embolus or chronic kidney disease. This is commonly labelled
as a ‘falsely elevated’ troponin although there is some myocardial strain to explain the rise, such as an increase in
cardiac oxygen demand. True ‘falsely elevated’ troponin, characterized by a persistent elevation in the absence of
cardiac injury does occur and thought to be secondary to an immunoglobulin-troponin complex (macrotroponin).
...................................................................................................................................................................................................
Case summary A 53-year-old gentleman with a background of diabetes, hypertension, hypercholesterolaemia, and hepatitis B was
admitted with chest pain and persistently elevated cardiac troponin T (cTnT) levels. Investigations revealed unob-
structed coronary arteries and a structurally normal, well-functioning heart. Subsequent biochemical analysis found
the persistently elevated cTnT secondary to macrotroponin T.
...................................................................................................................................................................................................
Discussion Macrotroponin, an immunoglobulin-troponin bound complex should be considered as a differential diagnosis when
the biochemistry is not reflective of the clinical picture. Early recognition requires effective collaboration with the
biochemistry laboratory for accurate diagnosis.
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Learning points
• A thorough review of the case is indicated when the biochemistry does not reflect the clinical picture.
• Close collaboration between the clinicians and the clinical biochemistry laboratory is vital in establishing an early diagnosis of a falsely ele-
vated troponin level.
• Falsely elevated troponin levels due to an immunoglobulin-G-cardiac complex should be a differential diagnosis when the troponin levels
do not reflect the clinical picture.
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Introduction
The measurement of cardiac troponin as cardiac troponin T (cTnT)
or cardiac troponin I (cTnI) is integral to the diagnosis of acute
myocardial infarction (AMI) and is included as the cornerstone of the
universal definition of AMI.1 Elevation of cardiac troponin also occurs
in a large number of clinical conditions associated with acute or
chronic myocardial injury but which are not classical AMI.1,2 These
may include myocardial infarction (MI) with non-obstructed coronary
arteries such as coronary vasospasm, pulmonary embolus, sepsis, and
chronic causes such as chronic kidney disease or structural heart dis-
ease.1,2 Although these are often referred to as ‘false positive’, this is
not in fact the case as there is underlying myocardial injury.1
However, a true ‘false positive’ troponin rise does occur which is
characterized by a persistent elevation in the absence of myocardial
injury and needs to be recognized by clinicians.
Timeline
Case presentation
A 53-year-old south Asian male presented to the accident and emer-
gency department with an extended history of chest pain and numb-
ness in the left arm lasting more than 24 hours. His symptoms had
initiated whilst driving but resolved on arrival to hospital. There were
no abnormal findings on clinical examination (heart rate 65 b.p.m.,
blood pressure 108/76 mmHg, saturations 98% on air, respiratory
rate 16 cycles per minute).
His medical background included type 2 diabetes (2013), hyper-
tension (2014), hypercholesterolaemia (2002), non-alcoholic steato-
hepatitis (2002), and hepatitis B (2002). The patient had two prior
admissions with cTnT positive chest pain, in 2002 (1410 ng/L) and
2015 (1540 ng/L), during which coronary angiography demonstrated
unobstructed coronary anatomy and a diagnosis of probable myocar-
ditis was given on each occasion.
An electrocardiogram (ECG) on admission demonstrated no
ischaemic changes (Figure 1). However, an initial cTnT was raised at
1588 ng/L (normal range <15 ng/L) and 1842 ng/L when repeated.
This was in the context of a normal renal function [creatinine 102
(normal 62–106 lmol/L)] and a normal haemoglobin (137 g/L).
Subsequent serial troponins did not drop below 1600 ng/L (timeline).
Due to this stagnation, a creatine kinase level was measured and
found to be only borderline raised at 338 U/L (normal 40–320 U/L).
An echocardiogram was also performed which showed no regional
wall motion abnormalities and a preserved left ventricular ejection
fraction of 60–65%.
Owing to the patient’s clinical picture, a CT aortagram was per-
formed which excluded an aortic dissection and within its limits, a
pulmonary embolus. Thus, a working diagnosis of acute coronary
syndrome was suggested and he underwent a coronary angiogram.
This showed only mild disease in the right coronary artery
(Supplementary material online, Video S1) and left anterior descend-
ing (Supplementary material online, Video S2) whilst the left main
stem and circumflex vessels (Supplementary material online, Video
S3) were unobstructed. Subsequently a cardiac MRI with gadolinium
was performed which was unremarkable and confirmed preserved
bi-ventricular function (Supplementary material online, Videos S4 and
S5) with no evidence of a scar, fibrosis, or oedema (Supplementary
material online, Video S6). Acute myocardial injury was therefore con-
sidered unlikely. Furthermore, he remained on telemetry and despite
7 days of cardiac monitoring, no arrhythmia was documented. After
extensive investigations had excluded myocardial damage and any
other clinical condition as a likely cause of the troponin elevation, the
biochemistry laboratory was contacted for assistance in elucidating
the cause of the persistently elevated cTnT.
Initially, a measurement of cTnI was performed (Abbott diagnos-
tics hs cTnI, LOD 2 ng/L 10% CV = 4.7 ng/L, 99th percentile URL =
26.2 ng/L) on the cTnT sample value 1674 ng/L, and was <2 ng/L,
therefore excluding myocardial injury. Analytical interference causing
a false-positive cTnT result was then suspected.
Serial dilution of the sample using troponin free diluent was linear
(Figure 2) (recovery sample 73.1–94.7%, control 81.5–109.2%) al-
though recovery at a one in 10 dilution was <100% compared with
the control. This suggested that an analytical interference from an
interfering antibody (anti-mouse) was unlikely. The Roche cTnT assay
uses fragment antigen binding portions of 2 cTnT-specific mouse
monoclonal antibodies (MAbs) directed against epitopes in the cen-
tral region of human cTnT.
One control (Randox IA3, Randox, County Antrim), two control
patients (cTnT 2091 and 1637 ng/L) and two patient samples (cTnT
1745 and 1697 ng/L) were diluted one in two with troponin free
Day 0 Admission to cardiology
with assumed ACS
diagnosis [after com-
puted tomography
(CT) aortagram]
Troponin T 1588 (ng/L)
Day 1 Echocardiogram demon-
strated well-functioning
heart with no regional
wall motion
abnormalities
Troponin T 1842 (ng/L)
Day 2 Coronary angiogram
reveals unobstructed
coronary arteries
Troponin T 1690 (ng/L)
Day 4 Cardiac MRI performed
revealing a structurally
normal heart and no
evidence of scar
Troponin T 1789 (ng/L)
Day 5 Biochemistry lab con-
tacted to elucidate
cause of persistently
elevated troponin
Troponin T 1684 (ng/L)
Day 8 Troponin I found to be
normal and macrotro-
ponin complex
confirmed
Troponin T 1697 (ng/L)
2 Z. Akhtar et al.
D
ow
nloaded from
 https://academ
ic.oup.com
/ehjcr/article/4/3/1/5828459 by St G
eorge's U
niversity of London user on 27 August 2020
Figure 1 Electrocardiogram on admission demonstrating no ischaemic changes.
Figure 2 Graph demonstrating linear dilution of the patient’s cTnT sample of 1745 ng/L in keeping with a likely macrotroponin causing an analytical
interference.
False-positive troponin elevation due to an IgG-cardiac troponin T complex 3
D
ow
nloaded from
 https://academ
ic.oup.com
/ehjcr/article/4/3/1/5828459 by St G
eorge's U
niversity of London user on 27 August 2020
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..diluent and with polyethylene glycol (25% w/v). Samples were incu-
bated at room temperature for 10 minutes and centrifuged at
14000 g for 5 min. Troponin T was analysed in the supernatant.
Recovery was 705.8/1104 (63.9%) for the control material. For two
control patient’s recovery was 687/807.4 (85.1%) and 910/963.4
(94.5%). For the patient’s day 4 sample recovery was 10.8/794.4
(1.4%) and for day 5 8.7/770.3 (1.1%). The presence of a macro form
of cTnT was therefore confirmed. Subsequent electrophoresis using
sodium dodecyl sulfate polyacrylamide gel electrophoresis
(SDS-PAGE) and western blotting (immunofixation) with the M7
MAb anti-human cTnT (donated by Roche Diagnostics, Mannheim,
Germany) against human cTnT and mouse anti-human immuno-
globulin-G (IgG; IG266, Abcam, Cambridge, UK) revealed a cTnT-
IgG complex (Figure 3).
Following this diagnosis, reassurance was given and he was dis-
charged home with routine follow-up arranged. A subsequent out-
patient 24-hour Holter demonstrated only sinus rhythm, which
reaffirmed the unlikelihood of a cardiac arrhythmia and a dobutamine
stress echocardiogram found no evidence of inducible ischaemia with
a normal functioning heart. He was safely discharged from the cardi-
ology services.
Discussion
Cardiac troponin is integral to the diagnosis of a myocardial infarc-
tion. Troponin rise from a MI occurs due to cardiac injury from acute
cardiac ischaemia, although elevated levels are also seen in acute or
chronic conditions not recognized as classical MI.1,2 This is often
referred to as a ‘false positive’ rise, which is not entirely true as there
is some underlying cardiac injury. The mechanism of injury may in-
clude a rise in cardiac oxygen demand, oxygen demand/supply mis-
match,3 and the fourth universal definition of MI addresses this by
distinguishing myocardial injury from MI.4 Interestingly, true analytical
false positives do occur which are thought to be secondary to macro-
troponin, an IgG complex attached to the troponin protein.5
In a clinical setting, elevation of cTnT due to macrotroponin
appears to be relatively uncommon and more frequently seen with
cTnI than cTnT.5 However, the overall prevalence of macrotropo-
nins may be more common than currently reported by clinicians.
For instance, cTnT autoantibodies have been found in up to 9.9% of
healthy blood donors6 and similarly, cTnI autoantibodies have been
found in up to 12.7%.7 This is comparable with the prevalence of
thyroglobulin and thyroperoxidase antibodies, which are commonly
encountered in clinical practice.7 It is therefore probable that the rise
in troponin levels attributed to clinical conditions other than MI,
could actually be due to macrotroponins.
This case illustrates the importance of clinical assessment of
patients admitted where the laboratory findings do not match the
clinical state of the patient and the importance of close collaboration
with the clinical chemistry laboratory. A significantly elevated tropo-
nin in an otherwise well individual should raise the suspicion of an
analytical interference. The clue in this case was the sustained eleva-
tion in the absence of any other clinical condition likely to produce an
elevated troponin of this magnitude. This led to an alternative tropo-
nin being measured which was normal and subsequently, to the diag-
nosis of the macrotroponin.
From this experience, it could be suggested that clinicians facing a
persistently elevated troponin with an atypical history and lack of evi-
dence suggestive of cardiac injury (ECG, echocardiography), should
consider measurement of an alternative troponin. Invasive investiga-
tions could be avoided unless the history is suggestive of another clin-
ical condition causing the rise. The important thing is to recognize the
lack of a dynamic change and lack of comorbidities likely to produce a
significant troponin elevation.
Conclusion
This case illustrates the importance of interpreting a troponin result
in the clinical context of the patient and underlines the importance of
clinical assessment of the patient. It also highlights the dangers of
over-reliance on uncritical acceptance of laboratory results. True
false-positive elevations of cardiac troponin from macrotroponins do
occur, though they are rare. Cases of macrotroponin I have been
reported in the literature, however, our case is the earliest
Figure 3 (A) Western blot of cTnT demonstrating intact free cTnT (lane 1) serum from index case (lane 2), serum from cTnT positive patients
(lanes 3 and 4). (B) Western blot of Human IgG control (lane 1), index case (lane 2) cTnT positive patients (lanes 3 and 4).
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..description of a falsely elevated troponin secondary to troponin T
autoantibodies in a clinical setting.
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